Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Hong Kong's Top 10 Financial News in 2025: "Hong Kong's Digital Economy Development Sees Enhanced Virtual Asset Regulatory Framework" Ranks Third

Hong Kong's Top 10 Financial News in 2025: "Hong Kong's Digital Economy Development Sees Enhanced Virtual Asset Regulatory Framework" Ranks Third

BlockBeatsBlockBeats2025/12/28 07:45

BlockBeats News, December 28th, The Wen Wei Po published the "Top Ten Financial News of Hong Kong 2025", in which "Development of the digital economy virtual asset regulatory framework tends to be perfected" ranked third. The "Stablecoin Regulation" was introduced to further improve the regulatory framework for digital asset activities in Hong Kong. The market expects that a stablecoin license will be issued in early 2026, and the Hong Kong dollar stablecoin is expected to be launched, which will be conducive to actual commercial trade and cross-border transactions.


In addition, "Cryptocurrency frenzy drives Bitcoin to a new high of $125,600" ranked eighth. Trump's vocal support for Bitcoin has repeatedly pushed its price to new all-time highs this year. However, it has since fallen back and at one point dropped to around $85,000, a drop of over 30% from its peak.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Why did the Reserve Bank of Australia raise interest rates two weeks ago? Meeting minutes reveal inflation risks have become a reality, and waiting would be too costly

The Reserve Bank of Australia acknowledges that the trade-off between inflation and full employment has worsened, but maintains that its goal is to return the Consumer Price Index (CPI) to the 2-3% target range.

智通财经•2026/10/13 02:41

Three-year remission rate up to 94%! Johnson & Johnson (JNJ.US) Tremfya Crohn's disease study shows positive long-term results

Long-term data from two Phase 3 clinical trials by Johnson & Johnson show that adult Crohn's disease patients treated with Tremfya (guselkumab) achieved a clinical remission rate of up to 94% over three years.

智通财经•2026/10/13 01:56